[DOI] [PMC free article] [PubMed] [Google Scholar] 255.Sa-Nguanmoo P., Tanajak P., Kerdphoo S., Jaiwongkam T., Pratchayasakul W., Chattipakorn N., Chattipakorn S.C
Ranibizumab (Lucentis) is also FDA-approved to treat wet macular degeneration
For more information, visit novonordisk.com , Facebook, Twitter, LinkedIn, YouTube
May slow photo aging including reducing wrinkles, fine lines and pigmentation changes
Final takeaways: GLP-1s face powerful internal and external pressures GLP-1s remain dominant but face growing challenges in safety, adherence and payer acceptance
Shorter telomeres are associated with accelerated biological aging, increased disease risk, and reduced tissue repair capacity